Use of Type 5 Single Nucleotide Polymorphisms Allows Noninvasive Prenatal Diagnosis for Consanguineous Families
Clinical Chemistry · 2024
DOI: 10.1093/clinchem/hvae040 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Erik A Sistermans. Beteiligte Einrichtung: Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Human Genetics, De Boelelaan 1117, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Consanguinity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Human Genetics, De Boelelaan 1117, Amsterdam, The Netherlands.
- Amsterdam Reproduction and Development, Amsterdam, The Netherlands.
ORCID-Profile: Erik A Sistermans
Zitieren
APA
Sistermans, E. A. (2024). Use of Type 5 Single Nucleotide Polymorphisms Allows Noninvasive Prenatal Diagnosis for Consanguineous Families. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae040
Vancouver
Sistermans EA. Use of Type 5 Single Nucleotide Polymorphisms Allows Noninvasive Prenatal Diagnosis for Consanguineous Families. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae040
BibTeX
@article{Sistermans2024,
author = {Sistermans, Erik A},
title = {Use of Type 5 Single Nucleotide Polymorphisms Allows Noninvasive Prenatal Diagnosis for Consanguineous Families},
journal = {Clinical Chemistry},
year = {2024},
doi = {10.1093/clinchem/hvae040}
}
EUVIMED